Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.

Christine Katlama; Roberto Esposito; Jose M Gatell; Jean-Christophe Goffard; Beatriz Grinsztejn; Anton Pozniak; Jurgen Rockstroh; Albrecht Stoehr; Norbert Vetter; Patrick Yeni

doi:10.1097/QAD.0b013e328013d9d7

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.

Identifier:nobleid.org/w1/20260515/6FE5DFBE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6FE5DFBE.svg?ark=w1%2F20260515%2F6FE5DFBE)](https://nobleid.org/work/w1/20260515/6FE5DFBE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Christine Katlama

Roberto Esposito

Jose M Gatell

Jean-Christophe Goffard

Claim authorship of this work

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.

Identifier:nobleid.org/w1/20260515/6FE5DFBE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6FE5DFBE.svg?ark=w1%2F20260515%2F6FE5DFBE)](https://nobleid.org/work/w1/20260515/6FE5DFBE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Christine Katlama

Roberto Esposito

Jose M Gatell

Jean-Christophe Goffard

Claim authorship of this work